Below some of the highlights I found researching

Below some of the highlights I found researching $AMBS again after 5Y+ or so. My opinion is that these highlights signal substantial positive change, but everyone should interpret it in their own way of course ..

Subsidiary / equity carve-outs complete;
Stakes in Todos & Emerald result in positive numbers on the balance sheet.
Improved IP, license, sublicense, JV, JC, royalty and, therefore, taxation structure.
All MANF research through university agreements where positive till date.
Positive results by Dr. Fumihiko Urano at Washington University regarding Wolfram.
Joana Neves is the 2019 grand prize winner of Sartorius & Science Prize for Regenerative Medicine & Cell Therapy.
Joana Neves + Buck Institute for Research on Aging + Years of government funding =
Neves discovered an evolutionarily conserved mechanism of tissue repair - immune modulation by the protein MANF - which she harnessed to restore visual function in old, blind mice with retinal disease.
Amarantus holds all licenses and patents.
Early this year Rob Rill takes substantial ownership into Todos Medical towards IPO.
IDEA Pharma to advise Amarantus on the road towards another successful IPO by them.
Enrollment for the LymPro PET 2.
Todos reports first commercial sales (government).
Todos Medical Enters Into Cross-Distribution Agreement With L1 Systems for Ventilators and COVID Testing
Todos Medical Signs Binding Term Sheet with HWH to market Blood Tests for Early Detection of BC.
Amarantus to operate in booming CBD market.
Researchers Claim CBD Can Modulate ACE-2 Expression In Gateway Tissues
Amarantus to operate in booming Telehealth market.
I probably forgot a few.
Almost forgot the Material Transfer Agreement with Dyadic International.

Highly speculative on my end:

Based on the above it could already mean that Amarantus is potentially receiving royalties (the later the annual filling, the more revenue to be stated?)
Feeling that ESS can only move forward after restructuring due to government regulations.
Feeling that MANF is part of one or multiple vaccine solutions. (E.g. Linebacker + Equivir).
Did Amarantus + ESS partake in project BioShield (BARDA)?
Did Amarantus + MANF partake in the panacea DARPA program?
Programs mentioned above and Geralds radio silence seem to correlate?
Last but not least, Amarantus to (reverse) merger with Dyadic?

These are my thoughts. Interpret the way you like. I’m positive.

Feel free to add and/or correct. Thanks.